BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7583710)

  • 1. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.
    Perez EA; Campbell DL; Ryu JK
    Cancer Invest; 1995; 13(6):604-7. PubMed ID: 7583710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recall dermatitis caused by re-exposure to docetaxel following irradiation of the brain. Case report and review of the literature].
    Giesel BU; Kutz GG; Thiel HJ
    Strahlenther Onkol; 2001 Sep; 177(9):487-93. PubMed ID: 11591023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation recall dermatitis after treatment of stage IV breast cancer with nivolumab: a case report.
    Billena C; Padia S; O'Brien B; Knoble J; Gokhale A; Rajagopalan M
    Immunotherapy; 2020 Feb; 12(2):123-130. PubMed ID: 31992119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation recall dermatitis after docetaxel administration: absolute indication to replace the drug?
    Borgia F; Guarneri C; Guarneri F; Vaccaro M
    Br J Dermatol; 2005 Sep; 153(3):674-5. PubMed ID: 16120169
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful rechallenge after ixabepilone-induced radiation recall dermatitis using an alternative dosing strategy.
    Ford JN; Newton M; Jordan C; Abraham J
    J Oncol Pharm Pract; 2013 Mar; 19(1):89-92. PubMed ID: 22323422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exemestane-induced radiation recall dermatitis and morbilliform rash.
    Marchand A; Georgin-Mège M; Cellier P; Martin L; Avenel-Audran M; Le Corre Y
    J Dermatol; 2016 May; 43(5):575-6. PubMed ID: 26813265
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiation recall dermatitis after pre-sensitization with pegylated liposomal doxorubicin.
    Gzell CE; Carroll SL; Suchowerska N; Beith J; Tan K; Scolyer RA
    Cancer Invest; 2009 May; 27(4):397-401. PubMed ID: 19219651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Barco I; Fraile M; Vidal M; Cambra MJ; Vallejo E; Deu J; González S; Giménez N; Pessarrodona A; García-Fernández A
    Breast J; 2018 Jul; 24(4):662-663. PubMed ID: 29517150
    [No Abstract]   [Full Text] [Related]  

  • 9. [Radiotherapy-induced pemphigus].
    Correia MP; Santos D; Jorge M; Coutinho S
    Acta Med Port; 1998 Jun; 11(6):581-3. PubMed ID: 9773540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma erysipeloides: an unusual presentation mimicking radiation dermatitis.
    Gugle A; Malpathak V; Zawar V; Deshmukh M; Kote R
    Dermatol Online J; 2008 Feb; 14(2):26. PubMed ID: 18700129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acne comedonica following radiation therapy].
    Karrer S; Schäfer CB; Allgäuer M; Landthaler M
    Dtsch Med Wochenschr; 1998 Apr; 123(17):527-30. PubMed ID: 9601475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of edatrexate in chemotherapy-naive patients with metastatic breast cancer.
    Schornagel JH; van der Vegt S; Verweij J; de Graeff A; Dullemond-Westland A; van Deijk WA; ten Bokkel Huinink WW
    Ann Oncol; 1992 Jul; 3(7):549-52. PubMed ID: 1498076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First Description of Docetaxel-Induced Recall Inflammatory Skin Reaction After Previous Drug Extravasation.
    Kramer F; Schippert C; Rinnau F; Hillemanns P; Park-Simon TW
    Ann Pharmacother; 2011 Feb; 45(2):e11. PubMed ID: 21266630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
    D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
    Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of edatrexate in patients with metastatic colorectal cancer.
    Clamon GH; Riggs CE; Dreicer R; Hohl RJ
    Invest New Drugs; 1996; 13(4):359-61. PubMed ID: 8824357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation recall dermatitis induced by trastuzumab.
    Moon D; Koo JS; Suh CO; Yoon CY; Bae J; Lee S
    Breast Cancer; 2016 Jan; 23(1):159-163. PubMed ID: 23543400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation recall dermatitis after the use of the anorexiant phentermine in a patient with breast cancer.
    Ash RB; Videtic GM
    Breast J; 2006; 12(2):186-7. PubMed ID: 16509853
    [No Abstract]   [Full Text] [Related]  

  • 18. Significant suppression of radiation dermatitis in breast cancer patients using a topically applied adrenergic vasoconstrictor.
    Cleary JF; Anderson BM; Eickhoff JC; Khuntia D; Fahl WE
    Radiat Oncol; 2017 Dec; 12(1):201. PubMed ID: 29273054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of Sweet's syndrome in radiation-induced locus minoris resistentae.
    Vergara G; Vargas-Machuca I; Pastor MA; Fariña MC; Martín L; Requena L
    J Am Acad Dermatol; 2003 Nov; 49(5):907-9. PubMed ID: 14576675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent radiation recall dermatitis triggered by radiological procedures in a patient with breast cancer.
    Emre S; Demirseren DD; Unal E; Sungu N
    Australas J Dermatol; 2019 Nov; 60(4):308-310. PubMed ID: 31012084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.